Literature DB >> 3661391

Usefulness of sex steroid hormone levels in predicting coronary artery disease in men.

J A Cauley1, J P Gutai, L H Kuller, W S Dai.   

Abstract

The relation between sex hormone levels and subsequent risk of a major coronary event was studied in a nested case-control study among 163 men in the Multiple Risk Factor Intervention Trial who later had a major coronary event and in 163 controls. Cases and controls were matched for age, serum cholesterol level, randomization group, randomization date and clinic. Blood samples were collected at baseline before randomization and frozen at -70 degrees C. Follow-up extended over 6 to 8 years. Sixty-one patients had a nonfatal acute myocardial infarction and 102 fatal infarction. Total and free testosterone, total and free estradiol, androstenedione and estrone concentrations were measured. There were no significant differences between cases and controls for any sex hormone level. There was also no difference in the ratio of testosterone to estradiol. Controlling for other cardiovascular risk factors did not change these results. These results do not support previous case-control studies of a relation between sex hormone levels and risk of heart attack among men.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661391     DOI: 10.1016/0002-9149(87)91021-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years.

Authors:  Laura R Stroud; Catherine Solomon; Edmond Shenassa; George Papandonatos; Raymond Niaura; Lewis P Lipsitt; Kaja Lewinn; Stephen L Buka
Journal:  Psychoneuroendocrinology       Date:  2007-01-31       Impact factor: 4.905

Review 2.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

3.  The effect of ketoconazole and transdermal estradiol on serum sex steroid hormones levels.

Authors:  G S Hughes; S F Francom; C R Spillers; T V Ringer
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Authors:  Stella Yi; Elizabeth Selvin; Sabine Rohrmann; Shehzad Basaria; Andy Menke; Nader Rifai; Eliseo Guallar; Elizabeth A Platz; Brad Astor
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

5.  Sex steroids and heart rate variability in patients after myocardial infarction.

Authors:  Jerzy Krzysztof Wranicz; Marcin Rosiak; Iwona Cygankiewicz; Piotr Kula; Krzysztof Kula; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

Review 6.  Risks and benefits of testosterone therapy in older men.

Authors:  Matthew Spitzer; Grace Huang; Shehzad Basaria; Thomas G Travison; Shalender Bhasin
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

7.  Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort.

Authors:  Katsiaryna Holl; Eva Lundin; Marjo Kaasila; Kjell Grankvist; Yelena Afanasyeva; Göran Hallmans; Matti Lehtinen; Eero Pukkala; Helja-Marja Surcel; Paolo Toniolo; Anne Zeleniuch-Jacquotte; Pentti Koskela; Annekatrin Lukanova
Journal:  Acta Oncol       Date:  2007-09-24       Impact factor: 4.089

8.  Progetto ATENA, a study on the etiology of major chronic diseases in women: design, rationale and objectives.

Authors:  S Panico; R Dello Iacovo; E Celentano; R Galasso; P Muti; M Salvatore; M Mancini
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

9.  Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study.

Authors:  Molly M Shores; Mary L Biggs; Alice M Arnold; Nicholas L Smith; W T Longstreth; Jorge R Kizer; Calvin H Hirsch; Anne R Cappola; Alvin M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  2014-03-14       Impact factor: 5.958

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.